Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358566
Status:
TERMINATED
Last Update Posted:
2008-05-19
First Post:
2006-07-14
Brief Title:
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Sponsor:
Pharmexa AS
Organization:
Pharmexa AS
Organization Data
Organization:
Pharmexa AS
Class:
INDUSTRY
Study ID:
PX11511-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pharmexa AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Ask Aabenhus Clinical Trial Manager
Old Organization:
Pharmexa AS
Collaborators
| Name | Class |
|---|---|
| Syneos Health | OTHER |
| ICON Clinical Research | INDUSTRY |
| ORION Clinical Services | INDUSTRY |
| CIRION Central Laboratory | UNKNOWN |
| Dorevitch | UNKNOWN |